Delta G New therapies from understanding ageing

Delta G's programmes <Archive>

Delta G is pursuing the development of therapeutics based on understanding how we age, and in particular how our bodies turn Calories into energy for our growth, healing and activity, and how that fails with age and in age-related diseases. Out principle programme is in cancer, where we are conducting research in collaboration with the Medical Research Council (see Collaborations). We also have discoveries in Chronic Fatigue Syndrome, and ar ei9n the process of in-licensing and developing further IP for new approaches to treatment of age-related disease.

Please click here for a short Background Reading document on biogerontology, the science of how we age, which is the ground in which Delta G grows its value.

Please click on the buttons above to learn more about our anti-cancer programmes, our other IP, and for some background reading material (including - Why 'Delta G'?).